Modeling the action of factor VIIa in dilutional coagulopathy

Thrombosis Research

Volumn 122, Issue SUPPL.1, 2008, Pages

  Monroe, Dougald M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antithrombin; Bleeding; Coagulopathy; Factor VIIa; Prothrombin

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 7A; PROTHROMBIN;

BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; DILUTIONAL COAGULOPATHY; DRUG EFFECT; DRUG MECHANISM; HUMAN; MODEL; PRIORITY JOURNAL; REVIEW; THROMBIN TIME; THROMBOCYTE ACTIVATION;

ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; FACTOR IX; FACTOR VIIA; FACTOR X; HEMODILUTION; HEMORRHAGE; HUMANS; MODELS, BIOLOGICAL; PROTHROMBIN; THROMBIN;

EID: 48449087348     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(08)70010-0     Document Type: Review

References (24)

1. Hardy J., de Moerloose P., and Samama C.M. The coagulopathy of massive transfusion. Vox Sang 89 (2005) 123-127
2. Karkouti K., Beattie W.S., Wijeysundera D.N., Yau T.M., McCluskey S.A., Ghannam M., et al. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis. Transfusion 45 (2005) 26-34
3. Martinowitz U., Holcomb J.B., Pusateri A.E., Stein M., Onaca N., Freidman M., et al. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries. J Trauma 50 (2001) 721-729
4. Tobias J.D. Synthetic factor VIIa to treat dilutional coagulopathy during posterior spinal fusion in two children. Anesthesiology 96 (2002) 1522-1525
5. Park P., Fewel M.E., Garton H.J., Thompson B.G., and Hoff J.T. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients. Neurosurgery 53 (2003) 34-38 Discussion: 38-9.
6. Haan J., and Scalea T. A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature. Am Surg 71 (2005) 414-415
7. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 13 (1965) 516-530
8. Wielders S., Mukherjee M., Michiels J., Rijkers D.T., Cambus J.P., Knebel R.W., et al. The routine determination of the endogenous thrombin potential, first results in different forms of hyper and hypocoagulability. Thromb Haemost 77 (1997) 629-636
9. Regnault V., Hemker H.C., Wahl D., and Lecompte T. Phenotyping the haemostatic system by thrombography potential for the estimation of thrombotic risk. Thromb Res 114 (2004) 539-545
10. Allen G.A., Wolberg A.S., Oliver J.A., Hoffman M., Roberts H.R., and Monroe D.M. Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost 2 (2004) 402-413
11. Al Dieri R., Peyvandi F., Santagostino E., Giansily M., Mannucci P.M., Schved J.F., et al. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 88 (2002) 576-582
12. Allen G.A., Hoffman M., Roberts H.R., and Monroe D.M. Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia. Br J Haematol 134 (2006) 314-319
13. Butenas S., van 't Veer C., and Mann K.G. "Normal" thrombin generation. Blood 94 (1999) 2169-2178
14. Horne M., Merryman P.K., Cullinane A.M., Nghiem K., and Alexander H.R. The impact of major surgery on blood coagulation factors and thrombin generation. Am J Hematol 82 (2007) 815-820
15. Stuckey A., Ezban M., Hedner U., Hoffman M., Roberts H.R., and Monroe D.M. High dose factor VIIa corrects thrombin generation in a model of dilutional coagulopathy. J Thromb Haemost 5 Suppl 2 (2007) P-S-081.
16. Butenas S., Brummel K.E., Bouchard B.A., and Mann K.G. How factor VIIa works in hemophilia. J Thromb Haemost 1 (2003) 1158-1160
17. Monroe D.M., Hoffman M., Oliver J.A., and Roberts H.R. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 99 (1997) 542-547
18. Kjalke M., Kjellev S., and Rojkjaer R. Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist. J Thromb Haemost 5 (2007) 774-780
19. Gabriel D.A., Li X., Monroe D., and Roberts H.R. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets. J Thromb Haemost 2 (2004) 1816-1822
20. Kristensen J., Killander A., Hippe E., Helleberg C., Ellegard J., Holm M., et al. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 26 Suppl 1 (1996) 159-164
21. Poon M., D'Oiron R., Von Depka M., Khair K., Négrier C., Karafoulidou A., et al. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. J Thromb Haemost 2 (2004) 1096-1103
22. Galán A., Tonda R., Pino M., Reverter J.C., Ordinas A., and Escolar G. Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders. Transfusion 43 (2003) 885-892
23. Lisman T., Moschatsis S., Adelmeijer J., Nieuwenhuis H.K., and De Groot P.G. Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation. Blood 101 (2003) 1864-1870
24. Lisman T., Adelmeijer J., Cauwenberghs S., Van Pampus E., Heemskerk J.W.M., and De Groot P.G. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count. J Thromb Haemost 3 (2005) 742-751